TrialThe Lancet. Infectious diseases2016

Safety and immunogenicity of RTS,S/AS01 malaria vaccine in infants and children with WHO stage 1 or 2 HIV disease: a randomised, double-blind, controlled trial.

Lucas Otieno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.